Carcinoma, Transitional Cell Concept

subject area of

• 2-[125I]iodomelatonin-binding sites in the human kidney and the effect of guanosine 5'-O-(3-thiotriphosphate).  Journal Articles
• 5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney)  Journal Articles
• A NOVEL INTRAVESICAL THERAPY FOR SUPERFICIAL BLADDER CANCER IN AN ORTHOTOPIC MODEL: ONCOLYTIC REOVIRUS THERAPY  Journal Articles
• A multinomial Phase II study of lonafarnib (SCH 66336) in patients with refractory urothelial cancer☆  Journal Articles
• A nomogram including baseline prognostic factors to estimate the activity of second‐line therapy for advanced urothelial carcinoma  Journal Articles
• A novel intravesical therapy for superficial bladder cancer in an orthotopic model: oncolytic reovirus therapy.  Journal Articles
• Angiotensin Blockade Modulates the Activity of PD1/L1 Inhibitors in Metastatic Urothelial Carcinoma  Journal Articles
• Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2)  Journal Articles
• Association between lymph node yield and survival among patients undergoing radical nephroureterectomy for urothelial carcinoma of the upper tract  Journal Articles
• Bone Metastases as the Only Metastatic Site in Patients With Urothelial Carcinoma: Focus on a Special Patient Population  Journal Articles
• Can Oncogenic Driver Alterations be Responsible for the Lack of Immunotherapy Efficacy in First-line Advanced Urothelial Carcinoma?  Journal Articles
• Cellular heterogeneity in normal and neoplastic human urothelium: A study using murine monoclonal antibodies  Journal Articles
• Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNA  Journal Articles
• Chemotherapy for metastatic transitional carcinoma of the urinary tract:A prospective trial of methotrexate, adriamycin, and cyclophosphamide (MAC) with cis-platinum for failure  Journal Articles
• Circulating Tumor DNA Alterations in Advanced Urothelial Carcinoma and Association with Clinical Outcomes: A Pilot Study  Journal Articles
• Cisplatin- Versus Non–Cisplatin-based First-Line Chemotherapy for Advanced Urothelial Carcinoma Previously Treated With Perioperative Cisplatin  Journal Articles
• Clinical Outcomes of Platinum-ineligible Patients with Advanced Urothelial Carcinoma Treated With First-line PD1/L1 Inhibitors  Journal Articles
• Comparison of oncological outcomes for open and laparoscopic radical nephroureterectomy: results from the Canadian Upper Tract Collaboration  Journal Articles
• Development of a 90-Minute Integrated Noninvasive Urinary Assay for Bladder Cancer Detection  Journal Articles
• Docetaxel As Monotherapy or Combined With Ramucirumab or Icrucumab in Second-Line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma: An Open-Label, Three-Arm, Randomized Controlled Phase II Trial  Journal Articles
• Durvalumab Plus Olaparib in Previously Untreated, Platinum-Ineligible Patients With Metastatic Urothelial Carcinoma: A Multicenter, Randomized, Phase II Trial (BAYOU)  Journal Articles
• Editorial Comment  Journal Articles
• Editorial Comment  Journal Articles
• Effects of intravesical chemotherapy and immunotherapy on semen analysis  Journal Articles
• Efficacy and Safety of Gemcitabine Plus Either Taxane or Carboplatin in the First-Line Setting of Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis  Journal Articles
• Efficacy and Safety of nab-Paclitaxel vs Paclitaxel on Survival in Patients With Platinum-Refractory Metastatic Urothelial Cancer  Journal Articles
• Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma  Journal Articles
• Expression of p53 in urothelial cell cultures from tumour-bearing and tumour-free patients  Journal Articles
• Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors  Journal Articles
• Further Investigation of the Response of Human Uroepithelium to Low Doses of Cobalt-60 Gamma Radiation  Journal Articles
• GNRH family genes contributed to gender-specific disparity of bladder cancer prognosis through exerting opposite regulatory roles between males and females  Journal Articles
• How I Do It: Maintenance avelumab for advanced urothelial carcinoma.  Journal Articles
• Impact of Prior Platinum-Based Therapy on Patients Receiving Salvage Systemic Treatment for Advanced Urothelial Carcinoma  Journal Articles
• Improved 5-Factor Prognostic Classification of Patients Receiving Salvage Systemic Therapy for Advanced Urothelial Carcinoma  Journal Articles
• Intra-Arterial Cisplatin for Bladder Cancer  Journal Articles
• Investigation of human papillomavirus in transitional cell carcinomas of the urinary bladder in South Africa  Journal Articles
• JAVELIN: avelumab another spear to fight urothelial carcinoma  Journal Articles
• Multifocality rather than tumor location is a prognostic factor in upper tract urothelial carcinoma  Journal Articles
• Neoadjuvant Chemotherapy for Transitional Cell Carcinoma of the Bladder: A Systematic Review and Meta-Analysis  Journal Articles
• Nomogram to Assess the Survival Benefit of New Salvage Agents for Metastatic Urothelial Carcinoma in the Era of Immunotherapy  Journal Articles
• Nomogram to predict the benefit from salvage systemic therapy for advanced urothelial carcinoma  Journal Articles
• Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel  Journal Articles
• Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review  Journal Articles
• Outcomes in patients with advanced urothelial carcinoma after discontinuation of programmed death (PD)‐1 or PD ligand 1 inhibitor therapy  Journal Articles
• Patient Eligibility and Trial Design for the Salvage Therapy of Advanced Urothelial Carcinoma  Journal Articles
• Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of AGS15E Monotherapy in Patients with Metastatic Urothelial Carcinoma  Journal Articles
• Posttreatment prognostic nomogram for patients with metastatic urothelial cancer completing first-line cisplatin-based chemotherapy  Journal Articles
• Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non–muscle-invasive Bladder Cancer  Journal Articles
• Primary results of STRONG: An open-label, multicenter, phase 3b study of fixed-dose durvalumab monotherapy in previously treated patients with urinary tract carcinoma  Journal Articles
• Prostate sparing radical cystectomy--not for all, but an option for some.  Journal Articles
• Reply from Authors re: Tracy L. Rose, Matthew I. Milowsky. A Small Step Toward Improving Salvage Treatment for Metastatic Bladder Cancer — At What Cost? Eur Urol 2016;69:642–44  Journal Articles
• Robot-assisted Versus Open Radical Cystectomy in Patients Receiving Perioperative Chemotherapy for Muscle-invasive Bladder Cancer: The Oncologist’s Perspective from a Multicentre Study  Journal Articles
• Selective reovirus killing of bladder cancer in a co-culture spheroid model  Journal Articles
• Synchronous transitional cell carcinoma and metastatic hepatocellular carcinoma in the urinary bladder: a case report.  Journal Articles
• Systematic Review of the Incidence of and Risk Factors for Urothelial Cancers and Renal Cell Carcinoma Among Patients with Haematuria  Journal Articles
• Systemic treatments for metastatic urothelial carcinoma  Journal Articles
• The Impact of Histologic Subtypes on Clinical Outcomes After Radiation-Based Therapy for Muscle-Invasive Bladder Cancer  Journal Articles
• The Koch pouch: radiographic evaluation of the orthotopic and cutaneous forms.  Journal Articles
• The emerging treatment landscape of advanced urothelial carcinoma  Journal Articles
• The method of bladder cuff excision during laparoscopic radical nephroureterectomy does not affect oncologic outcomes in upper tract urothelial carcinoma  Journal Articles
• Thromboembolic events in patients with urothelial carcinoma undergoing neoadjuvant chemotherapy and radical cystectomy  Journal Articles
• Tolerance of Radiotherapy and Chemotherapy in Elderly Patients With Bladder Cancer  Journal Articles
• Trends in utilisation, perioperative outcomes, and costs of nephroureterectomies in the management of upper tract urothelial carcinoma: a 10‐year population‐based analysis  Journal Articles
• Upper Tract Urothelial Carcinomas: Prognostic Factors and Outcomes in Patients With Non–Lymph Node Distant Metastasis  Journal Articles
• Urinary diversion using the Kock ileal reservoir in patients with irradiated bowel.  Journal Articles
• Urothelial Bladder Cancer with Cavitary Lung Metastases  Journal Articles
• [Microsatellite instability in urine sediments from patients with transitional cell carcinoma of bladder and its clinical value].  Journal Articles
• [Personal and histopathological factors as prognostic variables in upper urothelial tumors undergoing surgery].  Journal Articles